BACKGROUND
Exponential development within the inhabitants of older adults presents clinicians with particular issues about elements affecting dangers for declines in cognitive and bodily functioning.
OBJECTIVE
To look at the speculation that dangers for such declines and for illness outcomes, reminiscent of heart problems, are associated to variations in allostatic load, the cumulative physiologic toll exacted on the physique over time by efforts to adapt to life experiences. To current an operational definition of allostatic load, together with preliminary proof of its predictive validity in relation to salient outcomes of growing older.
METHODS
Information from a longitudinal, community-based examine of profitable growing older had been used to develop a measure of allostatic load based mostly on 10 parameters reflecting ranges of physiologic exercise throughout a spread of necessary regulatory techniques. Allostatic load is the sum of the variety of parameters for which the topic was rated within the highest-risk quartile.
RESULTS
Larger allostatic load scores had been related to poorer cognitive and bodily functioning and predicted bigger decrements in cognitive and bodily functioning in addition to being related to an elevated danger for the incidence of heart problems, impartial of sociodemographic and well being standing danger elements.
CONCLUSIONS
Findings are per the conceptualization of allostatic load as an index of wear and tear and tear on the physique, with elevations in allostatic load predicting an elevated danger for a decline in cognitive and bodily functioning in addition to heart problems in a cohort of older women and men. From a scientific perspective, the idea of allostatic load might present the idea for a extra complete evaluation of main dangers within the growing older course of.
Human Galectin-1 |
MBS691972-005mg |
MyBiosource |
0.05mg |
EUR 450 |
Human Galectin-1 |
MBS691972-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1725 |
Galectin-1, Human |
E34M148H |
EnoGene |
5 μg |
EUR 155 |
Galectin-1, Human |
MBS8575305-0005mg |
MyBiosource |
0.005mg |
EUR 245 |
Galectin-1, Human |
MBS8575305-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 940 |
Mouse anti Human Galectin-1 Antibody, Mouse MAb |
MBS2543309-006mL |
MyBiosource |
0.06mL |
EUR 250 |
Mouse anti Human Galectin-1 Antibody, Mouse MAb |
MBS2543309-012mL |
MyBiosource |
0.12mL |
EUR 370 |
Mouse anti Human Galectin-1 Antibody, Mouse MAb |
MBS2543309-02mL |
MyBiosource |
0.2mL |
EUR 550 |
Human Galectin-1 (Gal-1) Antibody |
30005-05111 |
AssayPro |
150 ug |
EUR 215 |
RABBIT ANTI HUMAN GALECTIN-3:Biotin |
MBS222930-005mg |
MyBiosource |
0.05mg |
EUR 655 |
RABBIT ANTI HUMAN GALECTIN-3:Biotin |
MBS222930-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2780 |
Anti-Human Galectin-1 Antibody |
102-P131 |
ReliaTech |
100 µg |
EUR 245.7 |
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and anti-inflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity. |
Anti-Human Galectin-1 Antibody |
102-PA131AG |
ReliaTech |
50 µg |
EUR 157.5 |
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and antiinflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity. |
Anti-Human Galectin-1 Antibody |
102-PA131S |
ReliaTech |
100 µg |
EUR 126 |
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and antiinflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity. |
Human Galectin-1 (LGALS1) |
1-CSB-EP012882HU |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
Human Galectin-1 (LGALS1) |
1-CSB-EP012882HUb1 |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
human anti-human galectin-3 mAb(2D) |
E4A09H10-2D |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
human anti-human galectin-3 mAb(5F) |
E4A09H10-5F |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
human anti-human galectin-3 mAb(A5) |
E4A09H10-A5 |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
human anti-human galectin-3 mAb(G2) |
E4A09H10-G2 |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
human anti-human galectin-3 mAb(H3) |
E4A09H10-H3 |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
human anti-human galectin-3 mAb(T1) |
E4A09H10-T1 |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Human Galectin-1 Protein |
PRP1033-100g |
Abbkine |
100 µg |
EUR 309 |
Human Galectin-1 Protein |
PRP1033-1mg |
Abbkine |
1 mg |
EUR 1099 |
Human Galectin-1 Protein |
PRP1033-20g |
Abbkine |
20 µg |
EUR 79 |
Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody |
MBS2543310-006mL |
MyBiosource |
0.06mL |
EUR 250 |
Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody |
MBS2543310-012mL |
MyBiosource |
0.12mL |
EUR 370 |
Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody |
MBS2543310-02mL |
MyBiosource |
0.2mL |
EUR 550 |
human anti-human galectin-3 mAb(N13) |
E4A09H10-N13 |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
MBS2543912-006mL |
MyBiosource |
0.06mL |
EUR 250 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
MBS2543912-012mL |
MyBiosource |
0.12mL |
EUR 370 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
MBS2543912-02mL |
MyBiosource |
0.2mL |
EUR 550 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
MBS2543913-006mL |
MyBiosource |
0.06mL |
EUR 250 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
MBS2543913-012mL |
MyBiosource |
0.12mL |
EUR 370 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
MBS2543913-02mL |
MyBiosource |
0.2mL |
EUR 550 |
Anti Human Galectin-3 Polyclonal Antibody |
KH040 |
Sceti |
each |
EUR 778.8 |
Description: The Anti Human Galectin-3 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur. |
Recombinant Human Galectin-1 |
7-00427 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human Galectin-1 |
7-00428 |
CHI Scientific |
50µg |
Ask for price |
Recombinant Human Galectin-1 |
AP60482 |
SAB |
100ug |
EUR 449 |
|
Recombinant Human Galectin-1 |
HEOPP-0710 |
Cyagen |
10ug |
Ask for price |
RECOMBINANT HUMAN GALECTIN-1 |
GWB-BEA2B0 |
GenWay Biotech |
0.05 mg |
Ask for price |
Recombinant Human Galectin-1 |
cyt-544-10g |
ProSpec Tany |
10µg |
EUR 60 |
Recombinant Human Galectin-1 |
cyt-544-1mg |
ProSpec Tany |
1mg |
EUR 1350 |
Recombinant Human Galectin-1 |
cyt-544-50g |
ProSpec Tany |
50µg |
EUR 145 |
Recombinant Human Galectin-1 |
MBS143303-001mg |
MyBiosource |
0.01mg |
EUR 240 |
Recombinant Human Galectin-1 |
MBS143303-005mg |
MyBiosource |
0.05mg |
EUR 310 |
Recombinant Human Galectin-1 |
MBS143303-1mg |
MyBiosource |
1mg |
EUR 1515 |
Recombinant Human Galectin-1 |
MBS143303-5x1mg |
MyBiosource |
5x1mg |
EUR 6485 |
RECOMBINANT HUMAN GALECTIN-1 |
MBS232407-005mg |
MyBiosource |
0.05mg |
EUR 500 |
RECOMBINANT HUMAN GALECTIN-1 |
MBS232407-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2070 |
Recombinant Human Galectin-1 |
P1229-.01 |
ApexBio |
10ug |
EUR 108.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human Galectin-1 |
P1229-.1 |
ApexBio |
10X10ug |
EUR 450.4 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human Galectin-1 |
P1229-.5 |
ApexBio |
50X10ug |
EUR 1010.4 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human Galectin-1 |
MBS9420409-002mg |
MyBiosource |
0.02mg |
EUR 285 |
Recombinant Human Galectin-1 |
MBS9420409-01mg |
MyBiosource |
0.1mg |
EUR 470 |
Recombinant Human Galectin-1 |
MBS9420409-1mg |
MyBiosource |
1mg |
EUR 1785 |
Sleep and the worth of plasticity: from synaptic and mobile homeostasis to reminiscence consolidation and integration.
- Sleep is common, tightly regulated, and its loss impairs cognition. However why does the mind must disconnect from the atmosphere for hours every single day? The synaptic homeostasis speculation (SHY) proposes that sleep is the worth the mind pays for plasticity.
- Throughout a waking episode, studying statistical regularities about the present atmosphere requires strengthening connections all through the mind. This will increase mobile wants for power and provides, decreases signal-to-noise ratios, and saturates studying.
- Throughout sleep, spontaneous exercise renormalizes internet synaptic energy and restores mobile homeostasis. Exercise-dependent down-selection of synapses can even clarify the advantages of sleep on reminiscence acquisition, consolidation, and integration.
- This occurs by the offline, complete sampling of statistical regularities included in neuronal circuits over a lifetime. This Perspective considers the rationale and proof for SHY and factors to open points associated to sleep and plasticity.
BACKGROUND
WHO and Well being Motion Worldwide (HAI) have developed a standardised technique for surveying drugs costs, availability, affordability, and worth elements in low-income and middle-income nations. Right here, we current a secondary evaluation of medication availability in 45 nationwide and subnational surveys performed utilizing the WHO/HAI methodology.
Influenza A (A / Brisbane / 10 / 07) H3N2 Protein |
abx060621-100g |
Abbexa |
100 µg |
Ask for price |
Influenza A (A / Brisbane / 10 / 07) H3N2 Protein |
abx060621-10g |
Abbexa |
10 µg |
EUR 2250 |
Influenza A (A / Brisbane / 10 / 07) H3N2 Protein |
abx060621-50g |
Abbexa |
50 µg |
Ask for price |
Influenza A virus H3N2 (Brisbane) Antigen |
VAC-0271 |
Creative BioMart |
0.5ml |
EUR 1598.4 |
Description: Protein |
Influenza A Virus H3N2 Brisbane 10/07 |
7-07948 |
CHI Scientific |
10µg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
7-07949 |
CHI Scientific |
50µg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
7-07950 |
CHI Scientific |
1mg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
MBS143232-001mg |
MyBiosource |
0.01mg |
EUR 240 |
Influenza A Virus H3N2 Brisbane 10/07 |
MBS143232-005mg |
MyBiosource |
0.05mg |
EUR 310 |
Influenza A Virus H3N2 Brisbane 10/07 |
MBS143232-1mg |
MyBiosource |
1mg |
EUR 2375 |
Influenza A Virus H3N2 Brisbane 10/07 |
MBS143232-5x1mg |
MyBiosource |
5x1mg |
EUR 10370 |
H3N2 Influenza-A Virus Brisbane 10/07 |
rAP-5410 |
Angio Proteomie |
Inquiry |
Ask for price |
H1N1 Influenza A- Virus Brisbane 59/2007 Recombinant |
rAP-5423 |
Angio Proteomie |
Inquiry |
Ask for price |
H3N2 Influenza A- Virus Brisbane 10/2007 Recombinant |
rAP-5428 |
Angio Proteomie |
Inquiry |
Ask for price |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (AP) |
MBS6481610-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (AP) |
MBS6481610-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (PE) |
MBS6481620-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (PE) |
MBS6481620-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A H1N1 (A/Brisbane/59/2007) HA protein, His Tag |
E40VAG011 |
EnoGene |
20ug |
EUR 495 |
Influenza A H3N2 (A/Brisbane/10/2007) HA protein, His Tag |
E40VAG023 |
EnoGene |
20ug |
EUR 495 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (APC) |
MBS6481611-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (APC) |
MBS6481611-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (HRP) |
MBS6481614-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (HRP) |
MBS6481614-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (FITC) |
MBS6481613-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (FITC) |
MBS6481613-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen |
11-567 |
ProSci |
0.1 mg |
EUR 632.4 |
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2) |
Influenza A Strain A/Brisbane/10/07 (H3N2) Protein |
GWB-T00035 |
GenWay Biotech |
1mg |
Ask for price |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (Biotin) |
MBS6481612-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (Biotin) |
MBS6481612-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
20-abx260509 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
abx260509-10g |
Abbexa |
10 µg |
EUR 325 |
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
abx260509-2g |
Abbexa |
2 µg |
EUR 225 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
11-563 |
ProSci |
0.05 mg |
EUR 632.4 |
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
11-564 |
ProSci |
0.05 mg |
EUR 632.4 |
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
Influenza B- Virus Brisbane 60/2008 Recombinant |
rAP-5434 |
Angio Proteomie |
Inquiry |
Ask for price |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 405) |
MBS6481615-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 405) |
MBS6481615-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 490) |
MBS6481616-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 490) |
MBS6481616-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 550) |
MBS6481617-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 550) |
MBS6481617-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 650) |
MBS6481618-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 650) |
MBS6481618-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 750) |
MBS6481619-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 750) |
MBS6481619-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza B (B/Brisbane/60/2008) HA protein, His Tag |
E40VAG161 |
EnoGene |
20ug |
EUR 495 |
Influenza B (B/Brisbane/60/2008) HA protein, His Tag |
E40VAG163 |
EnoGene |
20ug |
EUR 495 |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
IFLUABN1007H3N2ALR100UG |
Innovative research |
each |
EUR 738 |
|
Description: Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
MBS8431003-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin Antibody Pair Set |
ABPR-ZB267 |
Creative Diagnostics |
5 plates, 15 plates |
Ask for price |
Description: Quantitative determination of Influenza Hemagglutinin |
Influenza A H1N1 (A/Brisbane/59/2007) HA Protein (HA1 Subunit), His Tag |
E40VAG010 |
EnoGene |
20ug |
EUR 495 |
Influenza A H3N2 (A/Brisbane/10/2007) HA Protein (HA1 Subunit), His Tag |
E40VAG022 |
EnoGene |
20ug |
EUR 495 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set |
MBS8118343-15Plates |
MyBiosource |
15Plates |
EUR 800 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set |
MBS8118343-5Plates |
MyBiosource |
5Plates |
EUR 450 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set |
MBS8118343-5x15Plates |
MyBiosource |
5x15Plates |
EUR 3695 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb |
MBS8104742-002mL |
MyBiosource |
0.02mL |
EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb |
MBS8104742-01mL |
MyBiosource |
0.1mL |
EUR 365 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb |
MBS8104742-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1490 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104746-002mL |
MyBiosource |
0.02mL |
EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104746-01mL |
MyBiosource |
0.1mL |
EUR 385 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104746-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104747-002mL |
MyBiosource |
0.02mL |
EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104747-01mL |
MyBiosource |
0.1mL |
EUR 385 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104747-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104748-002mL |
MyBiosource |
0.02mL |
EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104748-01mL |
MyBiosource |
0.1mL |
EUR 385 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104748-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
Recombinant Influenza A virus A/Brisbane/02/2018 (H1N1) Hemagglutinin Antigen |
VAC-0017 |
Creative BioMart |
0.5ml |
EUR 2398.4 |
|
Description: Protein |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (HRP), Mouse MAb |
MBS8104743-01mg |
MyBiosource |
0.1mg |
EUR 440 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (HRP), Mouse MAb |
MBS8104743-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1820 |
Influenza B (B/Brisbane/60/2008) HA Protein (HA1 Subunit), His Tag |
E40VAG162 |
EnoGene |
20ug |
EUR 495 |
Influenza B (B/Brisbane/3/2007) HA Protein (HA1 Subunit), His Tag |
E40VAG283 |
EnoGene |
20ug |
EUR 495 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (Biotin), Rabbit MAb |
MBS8124089-01mg |
MyBiosource |
0.1mg |
EUR 470 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (Biotin), Rabbit MAb |
MBS8124089-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1955 |
Rabbit Anti-IBV (Influenza B/Brisbane/60/2008) HA2 Polyclonal Antibody |
CABT-CS796 |
Creative Diagnostics |
100 μg |
EUR 520 |
Description: Rabbit |
Influenza B hemagglutinin (aa1-585) (B/Brisbane/60/2008) cDNA clone |
MBS433511-1Each |
MyBiosource |
1Each |
EUR 420 |
Influenza B hemagglutinin (aa1-585) (B/Brisbane/60/2008) cDNA clone |
MBS433511-5x1Each |
MyBiosource |
5x1Each |
EUR 1740 |
Influenza A H1N1 (A/Brisbane/02/2018) Neuraminidase/NA Insect Cell Lysate (WB positive control) |
MBS8119887-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Influenza A H1N1 (A/Brisbane/02/2018) Nucleoprotein/NP Insect Cell Lysate (WB positive control) |
MBS8119889-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8114342-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8114342-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
MBS8114355-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
MBS8114355-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8114357-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8114357-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Recombinant Influenza B virus B/Brisbane/60/2008 Hemagglutinin antigen |
VAC-0113 |
Creative BioMart |
0.5ml |
EUR 2398.4 |
Description: Protein |
Influenza A H1N1pdm (Brisbane/2/18) Culture Fluid (Heat Inactivated) (1 mL) |
0810585CFHI |
Zeptometrix |
1 mL |
EUR 422 |
Recombinant Influenza A virus A/Brisbane/59/2007 (H1N1) Hemagglutinin Antigen (formaldehyde inactivated) |
VAC-0023 |
Creative BioMart |
0.5ml |
EUR 2398.4 |
Description: Protein |
Recombinant Influenza A virus A/Brisbane/59/2007 (H1N1) Hemagglutinin Antigen (formaldehyde inactivated) |
VAC-0024 |
Creative BioMart |
0.5ml |
EUR 2398.4 |
Description: Protein |
Recombinant Influenza A virus A/Brisbane/59/2007(H1N1) Hemagglutinin Antigen (propiolactone inactivated) |
VAC-0025 |
Creative BioMart |
0.5ml |
EUR 2398.4 |
Description: Protein |
Recombinant Influenza A virus A/Brisbane/59/2007(H1N1) Hemagglutinin Antigen (propiolactone inactivated) |
VAC-0026 |
Creative BioMart |
0.5ml |
EUR 2398.4 |
Description: Protein |
METHODS
Information from 45 WHO/HAI surveys in 36 nations had been adjusted for inflation or deflation and buying energy parity. Worldwide reference costs from open worldwide procurements for generic merchandise had been used as comparators. Outcomes are offered for 15 medicines included in a minimum of 80% of surveys and 4 particular person medicines.
RESULTS
Common public sector availability of generic medicines ranged from 29.4% to 54.4% throughout WHO areas. Median authorities procurement costs for 15 generic medicines had been 1.11 occasions corresponding worldwide reference costs, though buying effectivity ranged from 0.09 to five.37 occasions worldwide reference costs. Low procurement costs didn’t all the time translate into low affected person costs. Non-public sector sufferers paid 9-25 occasions worldwide reference costs for lowest-priced generic merchandise and over 20 occasions worldwide reference costs for originator merchandise throughout WHO areas. Remedies for acute and power sickness had been largely unaffordable in lots of nations. Within the personal sector, wholesale mark-ups ranged from 2% to 380%, whereas retail mark-ups ranged from 10% to 552%. In nations the place worth added tax was utilized to medicines, the quantity charged diverse from 4% to 15%.
CONCLUSIONS
Total, private and non-private sector costs for originator and generic medicines had been considerably increased than can be anticipated if buying and distribution had been environment friendly and mark-ups had been cheap. Coverage choices reminiscent of selling generic medicines and various financing mechanisms are wanted to extend availability, cut back costs, and enhance affordability.